How many people in past brain tumor studies had slow-growing tumors
Original title: Cohort-level proportions of low-grade glioma (WHO grades I-II) in mixed glioma cohorts: a single-arm meta-analysis for epidemiological benchmarking and clinical trial design.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This only counted tumor types in past studies. Nothing new was tested in people.
The short version
This study counted tumor types in brain tumor research that was already done.
What was studied. Researchers combined 191 past studies with 25,847 patients who had glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary, a type of brain tumor. They counted how many of those patients had a low-grade tumor, which grows more slowly.
What they found. Across all the studies, 57% of patients had a low-grade tumor. In studies that mixed low-grade and faster-growing tumors, it was 41%. In studies of low-grade tumors only, it was 82%. In trials that put patients in groups at random, it was 93%.
What this means, and what it doesn't
What it could mean: This does not change your care today. It helps researchers see who was in past studies. That makes it easier to plan new studies and compare results between hospitals.
What it doesn't mean: This is not a new treatment and it is not a cure. No drug, surgery, or therapy was tested here. The researchers only counted tumor types in studies that were already finished. It does not tell you how you or anyone else will do. It is a long way from changing what happens at your clinic visit.
Source: PubMed, October 7, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.